- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03410381
Ecological Momentary Mental Assessment (EMMA)
Development of an Algorithm and a Smartphone Application for the Evaluation and Prediction of Suicidal Risk
Suicide is a major health problem that causes annually a million death worldwide. Suicide and suicide attempts are preventable.
A history of self-injuries or suicidal attempts are known to be the most important risk factor for death by suicide. Suicidal ideation is also strongly correlated with suicide attempts.
The development of Smartphones applications offers new possibilities for data collection and transmission.
Moreover, the online help function, when a suicidal crisis occurs, is the most effective strategy for prevention of suicidal behavior.
Specific technologies have been developed to analyse behaviors and experiences of patients in a natural environment, in real life.
That is the goal of Ecological Momentary Assessment.
The aim of the study is to develop an algorithm to assess and predict the risk of suicidal event occurrence, in order to detect as soon as possible the signs of suicidal crisis.
EMMA will be the first application in French, meeting the recommendations for health applications, developed by experts on suicidal behavior and in collaboration with patients which aims to predict suicidal risk.
A subsequent study, conducted on a larger population, should allow to validate the predictive algorithm of EMMA.
Long-term goal is to improve the care of patients at risk for suicidal behavior.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
100 patients having recently attempted suicide or having suicidal ideation will be recruited. They will be asked to use the application EMMA during 6 months and will be followed up during this period.
An optional qualitative study conducted on 25 patients will allow to evaluate more finely their subjective experience of the use of the application.
Initial visit (inclusion) : clinical, biological and neuropsychological assessment and installation of the application EMMA.
First visit (1st month) and second visit (3rd month) : clinical assessment
Last visit (6th month) : clinical, biological and neuropsychological assessment and optional qualitative interview.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Montpellier, France, 34000
- MontpellierUniversity Hopital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Recent suicidal attempt (< 8 days) or suicidal ideation score ≥ 2 (IDSC-30 scale)
- More than 18 years old
- Able to understand nature, aims, and methodology oh the study
- To own a smartphone
Exclusion Criteria:
- Refusal to participate
- Patient on protective measures (guardianship or trusteeship)
- Deprived of liberty subject (administrative decision)
- Subject in exclusion period for another protocol
- Not affiliated to a social security agency
- Unable to understand and/or answer a questionnaire
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group using the application EMMA
Patients with personal history of suicide attempt or with suicidal ideation, will use the application during 6 months.
Assessment of the predictive value of the algorithm for suicidal risk, acceptbability and satisfaction
|
Emma proposes four types of assessments during 6 months:1) 5 times a day during 3 days, every month (5 minutes): patients can assess their emotions, their thoughts, their behavior and their occurrence context.
2) Weekly (7 minutes): consists of a summary of the week, about their emotions, thoughts, behavior, their relationships (family, work, friends, and their quality of life.3)
Monthly (5 minutes): assessment of the usefulness and satisfaction about the application.4)
Assessment available at any time An action plan is designed to support the participants, to help them facing difficult emotions and feelings, and to encourage them to ask for help.
They can contact a relative or call the psychiatric emergency service directly by clicking on a button.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Occurrence of a suicidal event during the follow-up
Time Frame: At 6 months
|
Occurrence of a suicidal event will be checked by the Columbia Suicide Severity Rating Scale (C-SSRS) questionnaire and medical records at the end of study.
|
At 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of the frequency of connection of the patient to the EMMA application
Time Frame: At 1 month
|
The use is automatically measured by the application with the connection frequency
|
At 1 month
|
|
Evaluation of the frequency of connection of the patient to the EMMA application
Time Frame: At 2 months
|
The use is automatically measured by the application with the connection frequency
|
At 2 months
|
|
Evaluation of the frequency of connection of the patient to the EMMA application
Time Frame: At 3 months
|
The use is automatically measured by the application with the connection frequency
|
At 3 months
|
|
Evaluation of the frequency of connection of the patient to the EMMA application
Time Frame: At 4 months
|
The use is automatically measured by the application with the connection frequency
|
At 4 months
|
|
Evaluation of the frequency of connection of the patient to the EMMA application
Time Frame: At 5 months
|
The use is automatically measured by the application with the connection frequency
|
At 5 months
|
|
Evaluation of the frequency of connection of the patient to the EMMA application
Time Frame: At 6 months
|
The use is automatically measured by the application with the connection frequency
|
At 6 months
|
|
Acceptability of EMMA assessed by the Smartphone application
Time Frame: At 1 month
|
Questionnaire passed with the application (Likert scales)
|
At 1 month
|
|
Acceptability of EMMA assessed by the Smartphone application
Time Frame: At 2 months
|
Questionnaire passed with the application (Likert scales)
|
At 2 months
|
|
Acceptability of EMMA assessed by the Smartphone application
Time Frame: At 3 months
|
Questionnaire passed with the application (Likert scales)
|
At 3 months
|
|
Acceptability of EMMA assessed by the Smartphone application
Time Frame: At 4 months
|
Questionnaire passed with the application (Likert scales)
|
At 4 months
|
|
Acceptability of EMMA assessed by the Smartphone application
Time Frame: At 5 months
|
Questionnaire passed with the application (Likert scales)
|
At 5 months
|
|
Acceptability of EMMA assessed by the Smartphone application
Time Frame: At 6 months
|
Questionnaire passed with the application (Likert scales)
|
At 6 months
|
|
Acceptability of EMMA assessed by the self assessment questionnaire Mobile Application Rating Scale (MARS)
Time Frame: At 6 months
|
At 6 months
|
|
|
Acceptability of EMMA assessed by a qualitative interview
Time Frame: At 6 months
|
The qualitative interview is optional
|
At 6 months
|
|
Satisfaction of EMMA assessed by the Smartphone application
Time Frame: At 1 month
|
Questionnaire passed with the application (Likert scales)
|
At 1 month
|
|
Satisfaction of EMMA assessed by the Smartphone application
Time Frame: At 2 months
|
Questionnaire passed with the application (Likert scales)
|
At 2 months
|
|
Satisfaction of EMMA assessed by the Smartphone application
Time Frame: At 3 months
|
Questionnaire passed with the application (Likert scales)
|
At 3 months
|
|
Satisfaction of EMMA assessed by the Smartphone application
Time Frame: At 4 months
|
Questionnaire passed with the application (Likert scales)
|
At 4 months
|
|
Satisfaction of EMMA assessed by the Smartphone application
Time Frame: At 5 months
|
Questionnaire passed with the application (Likert scales)
|
At 5 months
|
|
Satisfaction of EMMA assessed by the Smartphone application
Time Frame: At 6 months
|
Questionnaire passed with the application (Likert scales)
|
At 6 months
|
|
Satisfaction of EMMA assessed by the satisfaction questionnaire
Time Frame: At 6 months
|
At 6 months
|
|
|
Satisfaction of EMMA assessed by a qualitative interview
Time Frame: At 6 months
|
The qualitative interview is optional
|
At 6 months
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 9867
- 2017-A22108-45 (Other Identifier: Agence Nationale de Securité des Médicaments et produist de santé)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Person at Risk of Suicide
-
Florida State UniversityMilitary Suicide Research ConsortiumCompletedMilitary Service Members at Elevated Suicide RiskUnited States
-
Taipei Medical University HospitalDepartment of HealthCompletedCommunity Adolescents at Risk for Depression and SuicideTaiwan
-
Fundació Institut de Recerca de l'Hospital de la...Not yet recruitingSuicide | Suicide Risk | Suicide Attempt | Suicide Ideation | Suicide PreventionSpain
-
VA Office of Research and DevelopmentNot yet recruitingSuicide RiskUnited States
-
Hallym University Medical CenterNot yet recruitingSuicidal Ideation | Self-Injurious Behavior | Suicide Risk | Adolescent Mental Health
-
Uniformed Services University of the Health SciencesMassachusetts General Hospital; Beth Israel Deaconess Medical Center; University... and other collaboratorsRecruitingMental Health | Resilience | Risk Reduction Behavior | Suicide Prevention | Performance at Work | Risky BehaviorUnited States
-
The University of Texas Health Science Center at...Not yet recruitingSuicide Risk | Mild Traumatic Brain Injury | Suicide Prevention | Suicide Risk | Patient | Suicide Risk FactorUnited States
-
University of Massachusetts, WorcesterNational Institute of Mental Health (NIMH); Community HealthLink; Collective...Completed
-
Kaiser PermanenteNational Institute of Mental Health (NIMH); University of WashingtonEnrolling by invitationSuicide Prevention | Suicide Risk | PatientUnited States
-
Syeda AYAT E ZAINAB AliPakistan Institute of Living and Learning; MinPlan OrganizationRecruiting
Clinical Trials on Application EMMA
-
University Hospital, MontpellierFondation FondaMentalNot yet recruiting
-
Steno Diabetes Center CopenhagenUnknown
-
Henry M. Jackson Foundation for the Advancement...Boston University; Kenya Medical Research Institute; Kenya Ministry of Health; United...Completed
-
University of PittsburghWithdrawnMedication Adherence | Adverse Reaction to Drug | Medication NonadherenceUnited States
-
Mayo ClinicRecruiting
-
University of Illinois at ChicagoU.S. Army Medical Research and Development CommandWithdrawnPain | Posttraumatic Stress Disorders | Trauma | Traumatic Brain Injury | Combat DisordersUnited States
-
Mayo ClinicRecruiting
-
Nova Scotia Health AuthorityWithdrawnType2 Diabetes Mellitus
-
Peking University Third HospitalSun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Reproductive & Genetic...Not yet recruitingInfertility, Female | IVF
-
Washington State UniversityUnited States Department of DefenseRecruitingMild Cognitive Impairment | Subjective Cognitive ComplaintsUnited States